
According to a recent report from medical research website medical-tribune, e-cigarettes are not harmless to young people when it comes to lung diseases from a medical perspective. The study indicates that the risk of respiratory diseases doubles in comparison to those who do not use e-cigarettes among adolescents.
In a groundbreaking study, American researchers have found that the use of e-cigarettes can also trigger respiratory symptoms in adolescents and young adults. Participants were evaluated through online questionnaires, where they reported their complaints and provided information on their use of e-cigarettes, tobacco, and marijuana. The analysis covered the period from 2014 to 2018.
In comparison to individuals who never use e-cigarettes, those who use e-cigarettes have approximately double the odds of experiencing asthma (OR 1.81), bronchial discomfort (OR 2.06), and shortness of breath (OR 1.78) within the 30 days prior to the survey.
In a recent article, Alayna Tackett and her colleagues at the Columbus Waxner Medical Center argued that even after adjusting for factors such as smoking, marijuana use, and secondhand smoke exposure, these associations largely remained unchanged. Therefore, the authors suggest closely monitoring the potential harm of e-cigarettes on teenagers.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.